BIOXCEL THERAPEUTICS INC's ticker is BTAI and the CUSIP is 09075P105. A total of 21 filers reported holding BIOXCEL THERAPEUTICS INC in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $1,754 | -99.6% | 94,000 | +164.8% | 0.00% | +100.0% |
| Q3 2022 | $420,000 | -42.8% | 35,500 | -36.2% | 0.00% | 0.0% |
| Q2 2022 | $734,000 | +86.8% | 55,600 | +195.7% | 0.00% | – |
| Q1 2022 | $393,000 | -95.2% | 18,800 | -87.9% | 0.00% | -100.0% |
| Q2 2020 | $8,248,000 | +409.1% | 155,600 | +114.6% | 0.01% | +250.0% |
| Q1 2020 | $1,620,000 | +48.1% | 72,500 | -3.2% | 0.00% | +100.0% |
| Q4 2019 | $1,094,000 | +100.0% | 74,900 | -3.6% | 0.00% | – |
| Q3 2019 | $547,000 | -30.3% | 77,700 | +8.5% | 0.00% | -100.0% |
| Q2 2019 | $785,000 | +77.2% | 71,600 | +59.8% | 0.00% | – |
| Q1 2019 | $443,000 | – | 44,800 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Logos Global Management LP | 430,000 | $19,866,000 | 1.70% |
| APIS CAPITAL ADVISORS, LLC | 20,000 | $924,000 | 0.89% |
| Avidity Partners Management LP | 547,000 | $25,271,000 | 0.82% |
| Knoll Capital Management, LLC | 20,000 | $924,000 | 0.63% |
| Artemis Investment Management LLP | 1,013,448 | $46,839,000 | 0.49% |
| AlphaCentric Advisors LLC | 25,000 | $1,155,000 | 0.48% |
| First Light Asset Management, LLC | 94,202 | $4,352,000 | 0.32% |
| Ikarian Capital, LLC | 150,000 | $6,930,000 | 0.31% |
| Longitude (Cayman) Ltd. | 8,000 | $370,000 | 0.18% |
| AllSquare Wealth Management LLC | 5,490 | $254,000 | 0.17% |